Top

Published in:

01-10-2022 | Myalgie | News item

Sanofi UK recalls batches of teicoplanin due to bacterial endotoxins

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Sanofi is recalling two batches of teicoplanin (Targocid 200mg powder for solution for injection/infusion or oral solution) in the UK due to the presence of bacterial endotoxins, reports the Medicines and Healthcare products Regulatory Authority (MHRA). …

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Targocid 200mg powder for solution for injection/infusion or oral solution, Aventis Pharma Limited t/a Sanofi, due to the presence of bacterial endotoxins, NatPSA/2022/008/MHRA Internet Document : 26 Oct 2022. Available from: URL: https://bit.ly/3TXv4jj

Title: Sanofi UK recalls batches of teicoplanin due to bacterial endotoxins
Publication date: 01-10-2022
Publisher: Springer International Publishing
Keywords: Myalgie
Myalgia
Teicoplanin
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-26269-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Sanofi UK recalls batches of teicoplanin due to bacterial endotoxins

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Istradefylline overdose

Olanzapine

Apixaban

Ifosfamide

Isoniazid/linezolid

Multiple drugs